Treatment of moderate-to-severe atopic dermatitis (AD) after the approval of the first biologic agent: results from the german national registry TREATgermany
Stölzl D, Abraham S, Haufe E, Harder I, Heratizadeh A, Kleinheinz A, Weisshaar E, Wollenberg A, Zink A, Radtke M, Gerlach B, et al. (2019)
Experimental Dermatology 28(3): P088.
Kurzbeitrag Konferenz / Poster
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Stölzl, D.;
Abraham, S.;
Haufe, E.;
Harder, I.;
Heratizadeh, A.;
Kleinheinz, A.;
Weisshaar, E.;
Wollenberg, A.;
Zink, A.;
Radtke, M.;
Gerlach, B.;
Hilgers, M.
Alle
Alle
Erscheinungsjahr
2019
Serien- oder Zeitschriftentitel
Experimental Dermatology
Band
28
Ausgabe
3
Art.-Nr.
P088
Konferenz
46th Annual Meeting of the Arbeitsgemeinschaft-Dermatologische-Forschung (ADF)
Konferenzort
Munich, GERMANY
Konferenzdatum
2019-03-13 – 2019-03-16
ISSN
0906-6705
eISSN
1600-0625
Page URI
https://pub.uni-bielefeld.de/record/2968774
Zitieren
Stölzl D, Abraham S, Haufe E, et al. Treatment of moderate-to-severe atopic dermatitis (AD) after the approval of the first biologic agent: results from the german national registry TREATgermany. Experimental Dermatology. 2019;28(3): P088.
Stölzl, D., Abraham, S., Haufe, E., Harder, I., Heratizadeh, A., Kleinheinz, A., Weisshaar, E., et al. (2019). Treatment of moderate-to-severe atopic dermatitis (AD) after the approval of the first biologic agent: results from the german national registry TREATgermany. Experimental Dermatology, 28(3), P088
Stölzl, D., Abraham, S., Haufe, E., Harder, I., Heratizadeh, A., Kleinheinz, A., Weisshaar, E., et al. 2019. “Treatment of moderate-to-severe atopic dermatitis (AD) after the approval of the first biologic agent: results from the german national registry TREATgermany”, Experimental Dermatology, 28 (3): P088.
Stölzl, D., Abraham, S., Haufe, E., Harder, I., Heratizadeh, A., Kleinheinz, A., Weisshaar, E., Wollenberg, A., Zink, A., Radtke, M., et al. (2019). Treatment of moderate-to-severe atopic dermatitis (AD) after the approval of the first biologic agent: results from the german national registry TREATgermany. Experimental Dermatology 28:P088.
Stölzl, D., et al., 2019. Treatment of moderate-to-severe atopic dermatitis (AD) after the approval of the first biologic agent: results from the german national registry TREATgermany. Experimental Dermatology, 28(3): P088.
D. Stölzl, et al., “Treatment of moderate-to-severe atopic dermatitis (AD) after the approval of the first biologic agent: results from the german national registry TREATgermany”, Experimental Dermatology, vol. 28, 2019, : P088.
Stölzl, D., Abraham, S., Haufe, E., Harder, I., Heratizadeh, A., Kleinheinz, A., Weisshaar, E., Wollenberg, A., Zink, A., Radtke, M., Gerlach, B., Hilgers, M., Worm, M., von Kiedrowski, R., Wiemers, F., Staubach-Renz, P., Pawlak, M., Bell, M., Schäkel, K., Fell, I., Handrick, C., Asmussen, A., Bieber, T., Neubert, K., Homey, B., Schwarz, B., Effendy, I., Beissert, S., Werfel, T., Schmitt, J., Weidinger, S.: Treatment of moderate-to-severe atopic dermatitis (AD) after the approval of the first biologic agent: results from the german national registry TREATgermany. Experimental Dermatology. 28, : P088 (2019).
Stölzl, D., Abraham, S., Haufe, E., Harder, I., Heratizadeh, A., Kleinheinz, A., Weisshaar, E., Wollenberg, A., Zink, A., Radtke, M., Gerlach, B., Hilgers, M., Worm, M., von Kiedrowski, R., Wiemers, F., Staubach-Renz, P., Pawlak, M., Bell, M., Schäkel, K., Fell, I., Handrick, C., Asmussen, A., Bieber, T., Neubert, K., Homey, B., Schwarz, B., Effendy, Isaak, Beissert, S., Werfel, T., Schmitt, J., and Weidinger, S. “Treatment of moderate-to-severe atopic dermatitis (AD) after the approval of the first biologic agent: results from the german national registry TREATgermany”. Experimental Dermatology 28.3 (2019): P088.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Suchen in
Google Scholar